ClinConnect ClinConnect Logo
Search / Trial NCT04863677

The Effect of HIIT, MICT in Patients With Myocardial Infarction

Launched by GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL · Apr 26, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

High Intensity Intermittent Training Myocardial Infarction Moderate Intensity Continuous Training Cardiac Rehabilitation Cardiopulmonary Exercise Testing

ClinConnect Summary

This clinical trial is looking at how two different types of exercise programs, High-Intensity Interval Training (HIIT) and Moderate-Intensity Continuous Training (MICT), can help patients who have recently had a heart attack, also known as a myocardial infarction. The study will last for 12 weeks and aims to see how these workouts affect overall heart health, including improvements in fitness levels, heart function, body fat, and even mental well-being.

To participate, you need to be between 18 and 75 years old and have had a heart attack within the last 6 weeks to 3 months. You should also have undergone a procedure to improve blood flow to your heart and be willing to commit to the rehabilitation program. Participants will undergo fitness tests and will be monitored throughout the study. It's important to note that individuals with certain serious health conditions or who are already doing high-intensity exercise may not be eligible. This trial is a great opportunity for eligible patients to take an active step in their recovery while contributing to important research on heart health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Aged 18 -75 years
  • 2. Acute myocardial infarction (AMI) patients between 6 weeks and 3 months and had been underwent revascularization, and New York Heart Association functional classification (NYHA) Class I-III; (AMI confirmed by the World Health Organization definition (presence of symptoms of ischemia and changes in electrocardiogram) or the Third Universal Definition of Myocardial Infarction (elevation of a cardiac biomarker along with presence of either symptoms of myocardial infarction or changes in electrocardiogram))
  • 3. Willing and able to attend the complete cardiac rehabilitation(CR)program on their own,assigned the Informed consent form.
  • 4. Complete the cardiopulmonary exercise testing (CPET) at enrollment or has the CPET report within 1 month.
  • Exclusion Criteria:
  • 1. High-intensity exercise frequently
  • 2. Currently participating in any other clinical trials
  • 3. Have any other diseases which limit their life to less than a year (e.g. severe valvular disease, recurrent ventricular arrhythmias, NYHA Class IV heart failure, severe aortic incompetence, severe atrial fibrillation, cancers, and end-stage renal or liver disease)
  • 4. Dementia ; disability or sports contraindication
  • 5. Severe acute liver failure
  • 6. Severe acute renal failure
  • 7. Unstable vital signs
  • 8. Site investigators consider that the patient will be unable to complete the study and/or attend for follow-up.

About Guangdong Provincial People's Hospital

Guangdong Provincial People's Hospital is a leading tertiary healthcare institution located in Guangdong Province, China, renowned for its comprehensive medical services and advanced research capabilities. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical science through innovative research and the rigorous evaluation of new therapies and interventions. With a multidisciplinary team of experienced clinicians and researchers, the institution prioritizes patient safety and ethical standards while fostering collaborations with academic and industry partners to enhance healthcare outcomes and contribute to the global medical community.

Locations

Guangzhou, Guangdong, China

Patients applied

0 patients applied

Trial Officials

Qingshan Geng

Study Chair

Guangdong Provincial People's Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials